Tallinn, 2023-04-28 08:30 CEST
The subsidiary of J.Molner AS The J. Molner Company OÜ has decided to implement
changes in the work of the enterprise as a result of which the tasks of current
Qualified
Tallinn, 2023-04-20 08:30 CEST
The annual general meeting of shareholders of J.Molner AS (registry code
16579077, seat Akadeemia tee 21/5, 12618, Tallinn ) ('Company') was held on
19.04.2023 from 15:00
Tallinn, 2023-04-06 08:30 CEST
J. Molner AS, an Estonia-based pharmaceutical company specializing in the
development of innovative generic drugs, announces that it has entered into a
licensing agreement
Tallinn, 2023-03-17 08:30 CET
On March 10, 2023 J.Molner AS ('Company') published its annual interim
unaudited reports for 12 months of financial year 2022 for the Company and its
operating subsidiary
As of 9 January 2023 the sales agreement between Jason Grenfell-Gardner and
J.Molner AS in relation to the 100% shareholding in the company The J. Molner
Company, LLC (a Delaware (US) limited liability